J Holloman - BlackRock Science Independent Trustee
| BST Etf | USD 37.01 0.27 0.73% |
| Age | 66 |
| Tenure | 3 years |
| Phone | 212 810 5300 |
| Web | https://www.blackrock.com/investing/products/270141/blackrock-science-and-technology-trust-fund |
J Holloman Latest Insider Activity
Tracking and analyzing the buying and selling activities of J Holloman against BlackRock Science etf is an integral part of due diligence when investing in BlackRock Science. J Holloman insider activity provides valuable insight into whether BlackRock Science is net buyers or sellers over its current business cycle. Note, BlackRock Science insiders must abide by specific rules, including filing SEC forms every time they buy or sell BlackRock Science'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
J Holloman over three months ago Acquisition by J Holloman of 856 shares of BlackRock Credit subject to Rule 16b-3 | ||
J Holloman over three months ago Acquisition by J Holloman of 943 shares of BlackRock Credit at 9.54 subject to Rule 16b-3 | ||
J Holloman over six months ago Acquisition by J Holloman of 661 shares of BlackRock Credit subject to Rule 16b-3 | ||
J Holloman over six months ago Insider Trading |
Similar Fund Executives
| Showing other executives | One Year Return | ||
| Catherine Lynch | BlackRock Health Sciences | 60 | |
| Albert Laskaj | Cohen Steers Qualityome | 43 | |
| Sarah Cogan | Pimco Corporate Income | 65 | |
| Keith Quinton | Eaton Vance Enhanced | 63 | |
| MBA MD | Tekla Healthcare Investors | N/A | |
| Kelly McEwen | Reaves Utility If | 36 | |
| Keisha AudainPressley | Pimco Corporate Income | 46 | |
| W Kester | BlackRock Health Sciences | 70 | |
| Jason Nagler | Pimco Corporate Income | 39 | |
| Daphne Richards | Cohen Steers Reit | 54 | |
| Colleen Miller | Pimco Corporate Income | 41 | |
| Stayce Harris | BlackRock Health Sciences | 62 | |
| Jason Yablon | Cohen Steers Reit | 41 | |
| CFA CFA | BlackRock Utility Infrastructur | N/A | |
| Robert Fairbairn | Blackrock Innovation Growth | 56 | |
| Jeffrey Byer | Pimco Corporate Income | 45 | |
| Frank Fabozzi | Blackrock Innovation Growth | 73 | |
| Albert Laskaj | Cohen Steers Reit | 43 | |
| Marcus Smith | Eaton Vance Enhanced | 54 | |
| Kathleen Anderson | BlackRock Utility Infrastructur | N/A | |
| Cynthia Egan | BlackRock Health Sciences | 66 | |
BlackRock Science Tech Money Managers
| Henry Gabbay, Independent Trustee | ||
| Karen Robards, Independent Co-Chairman of the Board of Trustees | ||
| Richard Cavanagh, Independent Co-Chairman of the Board of Trustees | ||
| Charles Park, Chief Compliance Officer, Anti-Money Laundering Officer | ||
| Frank Fabozzi, Independent Trustee | ||
| J Holloman, Independent Trustee | ||
| Janey Ahn, Secretary | ||
| John Perlowski, President, Chief Executive Officer, Trustee | ||
| Michael Castellano, Independent Trustee | ||
| Cynthia Egan, Independent Trustee | ||
| Jay Fife, Treasurer | ||
| R Hubbard, Independent Trustee | ||
| Jonathan Diorio, Vice President | ||
| Robert Fairbairn, Trustee | ||
| Neal Andrews, Chief Financial Officer | ||
| Trent Walker, Chief Financial Officer | ||
| Catherine Lynch, Independent Trustee | ||
| Stayce Harris, Independent Trustee | ||
| W Kester, Independent Trustee |
BlackRock Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is BlackRock Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Shares Outstanding | 33.68 M | ||||
| Shares Owned By Insiders | 0.01 % | ||||
| Shares Owned By Institutions | 18.53 % | ||||
| Number Of Shares Shorted | 14.74 K | ||||
| Price To Earning | 5.78 X | ||||
| Short Ratio | 0.09 X | ||||
| Earnings Per Share | 5.41 X | ||||
| Number Of Employees | 17 | ||||
| Market Capitalization | 1 B | ||||
| Total Asset | 22.91 M |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.